Scientists hunt for early warning signs of ALS in Patients' blood
NCT ID NCT07268833
Summary
This study aims to discover new biological markers (biomarkers) for Amyotrophic Lateral Sclerosis (ALS) to help diagnose the disease earlier and track its progression. Researchers will analyze small nerve and skin samples, along with blood, from 400 participants, including people with ALS, those at genetic risk, and people with other neurological conditions for comparison. The goal is to identify specific proteins in the blood that signal early nerve damage, which could lead to better tests and future treatment targets.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AMYOTROPHIC LATERAL SCLEROSIS (ALS) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Azienda Ospedaliera Universitaria Federico II
RECRUITINGNaples, 80131, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Azienda Ospedaliero Universitaria di Cagliari
RECRUITINGMonserrato, California, 09042, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Fondazione IRCCS Istituto Neurologico Carlo Besta
RECRUITINGMilan, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
IRCCS Ospedale San Raffaele SRL
RECRUITINGMilan, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.